US Edition
News from The Courier-Tribune
Top The Courier-Tribune News
Startups · ShanghaiSHANGHAI, Aug. 11, 2025 /PRNewswire/ -- On August 11, Fosun Pharma (SSE:600196, HKEX: 02196) announced that its subsidiary Fosun Pharma Industrial has signed a License Agreement with Expedition Therapeutics Inc.(Expedition) to grant Expedition the rights to develop, manufacture, and commercialize…See the Story
Fosun Pharma's Small Molecule Innovative Drug XH-S004 Achieves Overseas Licensing for a Potential Total of $645 Million
68% Center coverage: 44 sources
Eli Lilly · United StatesWegovy® (semaglutide) injection 2.4 mg is now indicated to treat adults with metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), but not with cirrhosis of the liver, in conjunction with a reduced calorie diet and increased physical…See the Story
Wegovy® Approved by FDA for the Treatment of Adults with Noncirrhotic MASH with Moderate to Advanced Liver Fibrosis
56% Center coverage: 41 sources
Atlanta, Georgia · AtlantaATLANTA, Aug. 15, 2025 /PRNewswire/ -- Novelis Inc. (the "Company") announced today the results of its indirect wholly-owned subsidiary, Novelis Corporation's (the "Issuer") previously announced cash tender offer for any and all of its 3.250% Senior Notes due November 2026…See the Story
Novelis Announces Results of Tender Offer for 3.250% Senior Notes due November 2026
55% Center coverage: 38 sources
